10 Best Non-Tech Stocks to Buy Now for Long Term

Page 7 of 10

4. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 115  

Eli Lilly and Company (NYSE:LLY) develops and markets human pharmaceuticals. In the fourth full quarter of 2024, EPS increased 102% to $4.88 on a reported basis and 114% to $5.32 on a non-GAAP basis, both inclusive of $0.19 of acquired IPR&D charges. In February, the company acquired OliX Pharmaceuticals’ OLX702A for metabolic disease treatment for approximately 900 billion won. According to this contract, OliX must complete Phase 1 clinical trials for OLX75016. Following that, clinical development and commercialization will be handled by Eli Lilly, which will hold exclusive rights.

Page 7 of 10